JP2012525134A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525134A5
JP2012525134A5 JP2012507784A JP2012507784A JP2012525134A5 JP 2012525134 A5 JP2012525134 A5 JP 2012525134A5 JP 2012507784 A JP2012507784 A JP 2012507784A JP 2012507784 A JP2012507784 A JP 2012507784A JP 2012525134 A5 JP2012525134 A5 JP 2012525134A5
Authority
JP
Japan
Prior art keywords
seq
protein
ectodomain
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012507784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/055944 external-priority patent/WO2010125202A1/en
Publication of JP2012525134A publication Critical patent/JP2012525134A/ja
Publication of JP2012525134A5 publication Critical patent/JP2012525134A5/ja
Pending legal-status Critical Current

Links

JP2012507784A 2009-04-30 2010-04-30 インフルエンザ赤血球凝集素の組成物とその使用 Pending JP2012525134A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09159262 2009-04-30
EP09159262.6 2009-04-30
PCT/EP2010/055944 WO2010125202A1 (en) 2009-04-30 2010-04-30 Influenza hemagglutinin compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2012525134A JP2012525134A (ja) 2012-10-22
JP2012525134A5 true JP2012525134A5 (https=) 2013-06-06

Family

ID=42790940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012507784A Pending JP2012525134A (ja) 2009-04-30 2010-04-30 インフルエンザ赤血球凝集素の組成物とその使用

Country Status (9)

Country Link
US (1) US20120263743A1 (https=)
EP (1) EP2424570A1 (https=)
JP (1) JP2012525134A (https=)
CN (1) CN102573915B (https=)
AU (1) AU2010243490A1 (https=)
CA (1) CA2759873A1 (https=)
NZ (1) NZ596058A (https=)
SG (1) SG175382A1 (https=)
WO (1) WO2010125202A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106822887A (zh) * 2017-01-26 2017-06-13 中国科学院微生物研究所 一种流感病毒四价亚单位疫苗及其应用
SG11202109850SA (en) 2019-03-13 2021-10-28 Generation Bio Co Non-viral dna vectors and uses thereof for expressing fviii therapeutics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327382T3 (es) * 1999-07-20 2009-10-29 Morphosys Ag Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro.
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
DE60234375D1 (de) * 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
ES2316628T3 (es) * 2001-11-07 2009-04-16 Cytos Biotechnology Ag Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas.
US7138252B2 (en) * 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
RU2375076C2 (ru) * 2003-07-10 2009-12-10 Цитос Биотехнологи Аг Укомплектованные вирусоподобные частицы
CN101023103A (zh) * 2004-09-21 2007-08-22 赛托斯生物技术公司 包含ap205外壳蛋白和抗原性多肽的融合蛋白的病毒样颗粒
MX2007003171A (es) * 2004-09-21 2007-05-23 Cytos Biotechnology Ag Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico.
US8420102B2 (en) * 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
CA2615658A1 (en) * 2005-07-19 2007-01-25 Dow Global Technolgies Inc. Recombinant flu vaccines
AU2006279323B2 (en) * 2005-08-16 2013-08-01 Merck Sharp & Dohme Corp. Influenza recombinant subunit vaccine
KR101359723B1 (ko) * 2005-10-18 2014-02-05 노바백스, 인코포레이티드 기능성 인플루엔자 바이러스 유사 입자들
CA2636139A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
CU23576A1 (es) * 2006-02-28 2010-09-30 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la influenza aviar
CN101394864A (zh) * 2006-03-07 2009-03-25 法克斯因内特公司 包含血细胞凝集素的组合物、制造其的方法与使用其的方法

Similar Documents

Publication Publication Date Title
EP2646459B1 (en) Peptide scaffold design
EP2859011B1 (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
AU2012204955B2 (en) Monomeric and multimeric immunogenic peptides
JP2022172369A5 (https=)
JP2016199557A5 (https=)
JP2009511084A5 (https=)
JP2012526839A5 (https=)
JP2013526849A5 (https=)
WO2009026397A3 (en) Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
JP2012511322A5 (https=)
JP2010508030A5 (https=)
JP2013541528A5 (https=)
JP2010506926A5 (https=)
JP2018501258A5 (https=)
Sączyńska Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
JP2012525134A5 (https=)
WO2023220614A2 (en) Recombinant subunit based universal influenza and respiratory virus vaccines
JP2019534242A5 (https=)
WO2011056802A1 (en) Influenza virus recombinant proteins
CN105377876A (zh) 免疫原性肽缀合物及以之诱导抗流感治疗性抗体应答的方法
CN102573915B (zh) 流感血凝素组合物及其用途
US11535651B2 (en) Hepatitis B nanoparticle-based vaccine for influenza virus
RU2852174C1 (ru) Рекомбинантная вакцина против вируса гриппа а человека и способ ее получения
Kiršteina The immunoprotective and diagnostic potential of influenza virus haemagglutinin stalk domain for development of novel vaccine prototypes